The EHU’s Lipids & Liver group discover a key protein in the progression of liver diseases towards advanced stages An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver cancer. Metabolic fatty liver…
